|Articles|April 1, 2019
- Pharmaceutical Executive-04-01-2019
- Volume 39
- Issue 4
Pharmaceutical Executive, April 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Biosimilars Name Game Remains Thorny Issueabout 7 years ago
HBA's Woman of the Year 2019about 7 years ago
Sharing Your Voiceabout 7 years ago
Health Technology’s Double-Edged Swordabout 7 years ago
True Grit: Talent Management from the Ground Upabout 7 years ago
Reinventing Pharma’s Talent Searchabout 7 years ago
Hiring a Chief Diversity Officerabout 7 years ago
Are Pharma Marketers Fighting the Last War?about 7 years ago
Ready Patient Oneabout 7 years ago
Country Report: ChinaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5